Feasibility study of fluorine-18 labeled dopa for melanoma imaging

https://doi.org/10.1016/0883-2897(89)90102-5Get rights and content

Abstract

Feasibility of fluorine-18 labeled l-dopa for melanoma imaging was investigated. In B16 melanoma-bearing mice given 2-[18F]fluoro-l-dopa, the radioactivity in the B16 decreased for the first 60 min and then remained constant, while all other tissues investigated decreased with time. High tumor uptake ratios for all other tissues except for the pancreas were obtained at 120 min. 6-[18F]Fluoro-l-dopa showed a similar tissue distribution. However, the B16 uptake was about half that value for the 2-fluoro analogue. A higher incorporation rate of 2-[18F]fluoro-l-dopa into the acid-precipitable fraction of the melanoma also showed that the 2-[18F]fluoro-l-dopa was a preferable melanin precursor. Among the four kinds of non-melanoma tumors in mice or rats three tumors showed an uptake of 2-[18F]fluoro-l-dopa similar to the B16 at 60 min. However, larger melanoma-to-tissue uptake ratios were observed when compared to non-melanoma tumors.

References (29)

  • M.S. Blois

    Physical studies of the melanins

  • D.B. Calne et al.

    Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease

    Nature

    (1985)
  • U. Dunzendorfer et al.

    Synthesis and body distribution of alpha-aminoisobutyric acid-l-11C in normal and prostate cancer-bearing rat after chemotherapy

    Eur. J. Nucl. Med.

    (1981)
  • G. Firnau et al.

    Metabolites of 6-[18F]fluoro-l-dopa in human blood

    J. Nucl. Med.

    (1988)
  • Cited by (8)

    • 4-Borono-2-[<sup>18</sup>F]fluoro-d,l-phenylalanine: a possible tracer for melanoma diagnosis with PET

      1992, International Journal of Radiation Applications and Instrumentation.
    • Tumor uptake study of <sup>18</sup>F-labeled N-acetylneuraminic acids

      1990, International Journal of Radiation Applications and Instrumentation.
    • Molecular probes for malignant melanoma imaging

      2010, Current Pharmaceutical Biotechnology
    • Fluorinated tracers for imaging cancer with positron emission tomography

      2004, European Journal of Nuclear Medicine and Molecular Imaging
    View all citing articles on Scopus
    View full text